#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2169188	ADME	Metabolic stability of rat microsomes assessed as compound turnover at 1 uM after 30 mins by LC-MS analysis	Rattus norvegicus	25	ALA2163318	assay format	Scientific Literature
2.	ALA2169189	ADME	Metabolic stability of human microsomes assessed as compound turnover at 1 uM after 30 mins by LC-MS analysis	Homo sapiens	25	ALA2163318	assay format	Scientific Literature
3.	ALA2169190	Functional	Agonist activity at human GPR142 expressed in HEK293 cells assessed as inositol phosphate accumulation at 10 uM after 1 hr by scintillation counting	Homo sapiens	26	ALA2163318	cell-based format	Scientific Literature
4.	ALA2169191	Functional	Agonist activity at human GPR142 expressed in HEK293 cells assessed as inositol phosphate accumulation after 1 hr by scintillation counting	Homo sapiens	26	ALA2163318	cell-based format	Scientific Literature
5.	ALA2169193	Functional	Agonist activity at mouse GPR142 expressed in HEK293 cells by inositol phosphate accumulation assay	Mus musculus	1	ALA2163318	cell-based format	Scientific Literature
6.	ALA2169194	Functional	Antidiabetic activity in sc dosed B6D2F1 Harlan mouse assessed as decrease in blood glucose level administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
7.	ALA2169195	Functional	Antidiabetic activity in sc dosed B6D2F1 Harlan mouse assessed as increase in serum insulin level administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
8.	ALA2169196	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 0.10 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
9.	ALA2169402	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 0.30 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
10.	ALA2169403	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 1 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
11.	ALA2169404	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 3 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
12.	ALA2169405	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 5 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
13.	ALA2169406	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as decrease in blood glucose level at 30 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by glucometer analysis	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
14.	ALA2166402	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 0.10 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
15.	ALA2166403	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 0.30 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
16.	ALA2166404	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 1 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
17.	ALA2166405	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 3 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
18.	ALA2166406	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 5 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
19.	ALA2166407	Functional	Antidiabetic activity in B6D2F1 Harlan mouse assessed as increase in serum insulin level at 30 mg/kg, sc administered 15 mins prior glucose challenge measured 7.5 mins post glucose challenge by ELISA	Mus musculus	1	ALA2163318	organism-based format	Scientific Literature
20.	ALA2166411	ADME	Clearance in rat at 0.89 mg/kg, iv	Rattus norvegicus	1	ALA2163318	organism-based format	Scientific Literature